SERNOVA BIOTHERAPEUTICS INCSS

SERNOVA BIOTHERAPEUTICS INC

0.165CADD
−0.015−8.33%
Last update at 19:53 GMT
CAD
No tradesPost-market
See on Supercharts
Next report date
June 25
Report period
Q2 2025
EPS estimate
−0.03 CAD
Revenue estimate
0.00 CAD
Market capitalization
‪59.13 M‬CAD
−0.090CAD
‪−32.19 M‬CAD
0.00CAD
‪315.01 M‬
Beta (1Y)
−1.18
Employees (FY)
17
Change (1Y)
−9 −34.62%
Revenue / Employee (1Y)
0.00CAD
Net income / Employee (1Y)
‪−1.89 M‬CAD

About SERNOVA BIOTHERAPEUTICS INC


CEO
Jonathan M. N. Rigby
Headquarters
London
Founded
1998
FIGI
BBG000CDMHF9
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. It focuses on its proprietary Cell Pouch, a bio-hybrid organ system which is designed to enhance the delivery of cell therapy to better replicate natural body functions. The company was founded on August 19, 1998 and is headquartered in London, Canada.
Performance
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−6.00 M‬‬
‪‪−4.50 M‬‬
‪‪−3.00 M‬‬
‪‪−1.50 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−6.00 M‬‬
‪‪−4.50 M‬‬
‪‪−3.00 M‬‬
‪‪−1.50 M‬‬
‪0.00‬
Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−8.00 M‬‬
‪‪−4.00 M‬‬
‪0.00‬
‪‪4.00 M‬‬
‪‪8.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Jun 25, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪−0.03‬
‪−0.02‬
‪−0.02‬
‪−0.01‬
‪0.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SVA is 0.165 CAD — it has decreased by −8.33% in the past 24 hours. Watch SERNOVA BIOTHERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange SERNOVA BIOTHERAPEUTICS INC stocks are traded under the ticker SVA.
SVA stock hasn't changed in a week, the month change is a −7.69% fall, over the last year SERNOVA BIOTHERAPEUTICS INC has showed a −70.00% decrease.
We've gathered analysts' opinions on SERNOVA BIOTHERAPEUTICS INC future price: according to them, SVA price has a max estimate of 6.00 CAD and a min estimate of 0.60 CAD. Watch SVA chart and read a more detailed SERNOVA BIOTHERAPEUTICS INC stock forecast: see what analysts think of SERNOVA BIOTHERAPEUTICS INC and suggest that you do with its stocks.
SVA reached its all-time high on Jan 19, 2021 with the price of 2.870 CAD, and its all-time low was 0.020 CAD and was reached on Mar 20, 2009. View more price dynamics on SVA chart.
See other stocks reaching their highest and lowest prices.
SVA stock is 12.50% volatile and has beta coefficient of −1.18. Track SERNOVA BIOTHERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is SERNOVA BIOTHERAPEUTICS INC there?
Yes, you can track SERNOVA BIOTHERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
SERNOVA BIOTHERAPEUTICS INC is going to release the next earnings report on Jun 25, 2025. Keep track of upcoming events with our Earnings Calendar.
SVA earnings for the last quarter are −0.03 CAD per share, whereas the estimation was −0.03 CAD resulting in a −0.18% surprise. The estimated earnings for the next quarter are −0.03 CAD per share. See more details about SERNOVA BIOTHERAPEUTICS INC earnings.
SERNOVA BIOTHERAPEUTICS INC revenue for the last quarter amounts to 0.00 CAD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SVA net income for the last quarter is ‪−5.70 M‬ CAD, while the quarter before that showed ‪−4.97 M‬ CAD of net income which accounts for −14.64% change. Track more SERNOVA BIOTHERAPEUTICS INC financial stats to get the full picture.
No, SVA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 24, 2025, the company has 17.00 employees. See our rating of the largest employees — is SERNOVA BIOTHERAPEUTICS INC on this list?
Like other stocks, SVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SERNOVA BIOTHERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SERNOVA BIOTHERAPEUTICS INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SERNOVA BIOTHERAPEUTICS INC stock shows the strong sell signal. See more of SERNOVA BIOTHERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.